Regal Investment Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.18M Sell
10,821
-455
-4% -$169K 0.22% 122
2026
Q1
$3.3M Buy
11,276
+37
+0.3% +$12.2K 0.19% 137
2025
Q4
$3.94M Buy
11,239
+401
+4% +$136K 0.24% 110
2025
Q3
$3.5M Buy
+10,838
New +$3.37M 0.23% 117
2023
Q1
Sell
-415
Closed -$213K 525
2022
Q4
$213K Buy
+415
New +$211K 0.02% 439
2022
Q2
Sell
-481
Closed -$236K 511
2022
Q1
$236K Buy
+481
New +$220K 0.02% 466
2015
Q4
Sell
-20
Closed -$2K 441
2015
Q3
$2K Buy
20
+5
+33% +$751 ﹤0.01% 929
2015
Q2
$2K Buy
+15
New +$2.4K ﹤0.01% 839
2013
Q3
Sell
-15
Closed -$1K 890
2013
Q2
$1K Buy
+15
New +$1.12K ﹤0.01% 840

Other funds holding ELV

Regal Investment Advisors's ELV Position: Q2 2026 in Review

Regal Investment Advisors reduced its Elevance Health (ELV) stake by 4% in Q2 2026, selling an estimated $169K and leaving 10,821 shares worth $4.18M. The position accounts for 0.22% of the portfolio, ranked #122.

Regal Investment Advisors first reported a position in ELV in Q2 2013 and has held it in 9 quarters since. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Regal Investment Advisors held 10,821 shares of Elevance Health worth $4.18M as of Q2 2026.
  • Regal Investment Advisors sold 455 Elevance Health shares in Q2 2026, an estimated $169K.
  • Elevance Health made up 0.22% of Regal Investment Advisors's portfolio in Q2 2026, its #122 holding.
  • Regal Investment Advisors first reported a position in Elevance Health in Q2 2013 and has held it in 9 quarters since.
  • 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Regal Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.